P53 regulation of energy metabolism and mitochondria regulation of p53 in cancer cells: An insight into the role of manganese Superoxide Dismutase

Current Pharmaceutical Biotechnology

Volumn 14, Issue 3, 2013, Pages 261-273

  Sun, Yulan ^a   Holley, Aaron K ^a   St Clair, Daret K ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

Author keywords

Metabolism; Mitochondria; MnSOD; P53; ROS

Indexed keywords

CYTOCHROME C OXIDASE; HYPOXIA INDUCIBLE FACTOR; MAMMALIAN TARGET OF RAPAMYCIN; MANGANESE SUPEROXIDE DISMUTASE; PROLINE DEHYDROGENASE; PROTEIN KINASE B; PROTEIN MDMX; PROTEIN P53; PYRUVATE DEHYDROGENASE KINASE; REACTIVE OXYGEN METABOLITE; REDOX EFFECTOR FACTOR 1; SOMATOMEDIN BINDING PROTEIN; THIOREDOXIN REDUCTASE;

AMINO ACID METABOLISM; ANTIOXIDANT ACTIVITY; APOPTOSIS; ARTICLE; AUTOPHAGY; CANCER CELL; CELL CYCLE ARREST; CELL DEATH; CELL SURVIVAL; DNA DAMAGE; ENERGY METABOLISM; FATTY ACID METABOLISM; GENETIC TRANSCRIPTION; GLYCOLYSIS; HEMOSTASIS; HUMAN; METABOLIC STRESS; MITOCHONDRIAL RESPIRATION; MITOCHONDRION; NONHUMAN; OXIDATIVE PHOSPHORYLATION; OXIDATIVE STRESS; PROTEIN EXPRESSION; REGULATORY MECHANISM; RESPIRATORY CHAIN; SIGNAL TRANSDUCTION;

ANIMALS; ENERGY METABOLISM; HUMANS; MITOCHONDRIA; NEOPLASMS; SUPEROXIDE DISMUTASE; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84875287840     PISSN: 13892010     EISSN: 18734316     Source Type: Journal    
DOI: 10.2174/1389201011314030003     Document Type: Article

References (126)

1. Hollstein, M.; Sidransky, D.; Vogelstein, B.; Harris, C.C. p53 mutations in human cancers. Science, 1991, 253(5015), 49-53.
2. Greenblatt, M.S.; Bennett, W.P.; Hollstein, M.; Harris, C.C. Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res., 1994, 54(18), 4855-4878.
3. Haupt, Y.; Maya, R.; Kazaz, A.; Oren, M. Mdm2 promotes the rapid degradation of p53. Nature, 1997, 387(6630), 296-299.
4. Momand, J.; Wu, H. H.; Dasgupta, G. MDM2--master regulator of the p53 tumor suppressor protein. Gene, 2000, 242(1-2), 15-29.
5. Vousden, K. H.; Prives, C. Blinded by the Light: The Growing Complexity of p53. Cell, 2009, 137(3), 413-431.
6. Menendez, D.; Inga, A.; Resnick, M. A. The expanding universe of p53 targets. Nat. Rev. Cancer, 2009, 9(10), 724-737.
7. Vousden, K. H.; Ryan, K. M. p53 and metabolism. Nat. Rev. Cancer, 2009, 9(10), 691-700.
8. Liu, B.; Chen, Y.; St Clair, D. K. ROS and p53: a versatile partnership. Free Radic. Biol. Med., 2008, 44(8), 1529-1535.
9. Vaseva, A. V.; Moll, U. M. The mitochondrial p53 pathway. Biochim. Biophys. Acta, 2009, 1787(5), 414-420.
10. Achanta, G.; Sasaki, R.; Feng, L.; Carew, J. S.; Lu, W.; Pelicano, H.; Keating, M. J.; Huang, P. Novel role of p53 in maintaining mitochondrial genetic stability through interaction with DNA Pol gamma. EMBO J., 2005, 24(19), 3482-3492.
11. Wallace, D. C. Mitochondrial diseases in man and mouse. Science, 1999, 283(5407), 1482-8.
12. Warburg, O. On metabolism of tumors. Constable: London, 1930.
13. Warburg, O. On the origin of cancer cells. Science, 1956, 123(3191), 309-314.
14. Yeung, S. J.; Pan, J.; Lee, M. H. Roles of p53, MYC and HIF-1 in regulating glycolysis -the seventh hallmark of cancer. Cell Mol. Life Sci., 2008, 65(24), 3981-3999.
15. Schwartzenberg-Bar-Yoseph, F.; Armoni, M.; Karnieli, E. The tumor suppressor p53 down-regulates glucose transporters GLUT1 and GLUT4 gene expression. Cancer Res., 2004, 64(7), 2627-2633.
16. Kawauchi, K.; Araki, K.; Tobiume, K.; Tanaka, N. p53 regulates glucose metabolism through an IKK-NF-kappaB pathway and inhibits cell transformation. Nat. Cell Biol., 2008, 10(5), 611-618.
17. Kawauchi, K.; Araki, K.; Tobiume, K.; Tanaka, N. Loss of p53 enhances catalytic activity of IKKbeta through O-linked beta-Nacetyl glucosamine modification. Proc. Natl. Acad Sci. U S A., 2009, 106(9), 3431-3436.
18. Kondoh, H.; Lleonart, M. E.; Gil, J.; Wang, J.; Degan, P.; Peters, G.; Martinez, D.; Carnero, A.; Beach, D. Glycolytic enzymes can modulate cellular life span. Cancer Res., 2005, 65(1), 177-185.
19. Bensaad, K.; Tsuruta, A.; Selak, M. A.; Vidal, M. N.; Nakano, K.; Bartrons, R.; Gottlieb, E.; Vousden, K. H. TIGAR, a p53-inducible regulator of glycolysis and apoptosis. Cell, 2006, 126(1), 107-120.
20. Matoba, S.; Kang, J. G.; Patino, W. D.; Wragg, A.; Boehm, M.; Gavrilova, O.; Hurley, P. J.; Bunz, F.; Hwang, P. M. p53 regulates mitochondrial respiration. Science, 2006, 312(5780), 1650-1653.
21. Okamura, S.; Ng, C. C.; Koyama, K.; Takei, Y.; Arakawa, H.; Monden, M.; Nakamura, Y. Identification of seven genes regulated by wild-type p53 in a colon cancer cell line carrying a wellcontrolled wild-type p53 expression system. Oncol. Res., 1999, 11(6), 281-285.
22. Lebedeva, M. A.; Eaton, J. S.; Shadel, G. S. Loss of p53 causes mitochondrial DNA depletion and altered mitochondrial reactive oxygen species homeostasis. Biochim. Biophys. Acta, 2009, 1787(5), 328-334.
23. Park, J. Y.; Wang, P. Y.; Matsumoto, T.; Sung, H. J.; Ma, W.; Choi, J. W.; Anderson, S. A.; Leary, S. C.; Balaban, R. S.; Kang, J. G.; Hwang, P. M. p53 improves aerobic exercise capacity and augments skeletal muscle mitochondrial DNA content. Circ. Res., 2009, 105(7), 705-712, 11 p following 712.
24. Bourdon, A.; Minai, L.; Serre, V.; Jais, J. P.; Sarzi, E.; Aubert, S.; Chretien, D.; de Lonlay, P.; Paquis-Flucklinger, V.; Arakawa, H.; Nakamura, Y.; Munnich, A.; Rotig, A. Mutation of RRM2B, encoding p53-controlled ribonucleotide reductase (p53R2), causes severe mitochondrial DNA depletion. Nat. Genet., 2007, 39(6), 776-780.
25. Donahue, R. J.; Razmara, M.; Hoek, J. B.; Knudsen, T. B. Direct influence of the p53 tumor suppressor on mitochondrial biogenesis and function. FASEB J., 2001, 15(3), 635-644.
26. Chen, D.; Yu, Z.; Zhu, Z.; Lopez, C. D. The p53 pathway promotes efficient mitochondrial DNA base excision repair in colorectal cancer cells. Cancer Res., 2006, 66(7), 3485-3494.
27. Sablina, A. A.; Budanov, A. V.; Ilyinskaya, G. V.; Agapova, L. S.; Kravchenko, J. E.; Chumakov, P. M. The antioxidant function of the p53 tumor suppressor. Nat. Med., 2005, 11(12), 1306-1313.
28. Budanov, A. V.; Sablina, A. A.; Feinstein, E.; Koonin, E. V.; Chumakov, P. M. Regeneration of peroxiredoxins by p53-regulated sestrins, homologs of bacterial AhpD. Science, 2004, 304(5670), 596-600.
29. Hussain, S. P.; Amstad, P.; He, P.; Robles, A.; Lupold, S.; Kaneko, I.; Ichimiya, M.; Sengupta, S.; Mechanic, L.; Okamura, S.; Hofseth, L. J.; Moake, M.; Nagashima, M.; Forrester, K. S.; Harris, C. C. p53-induced up-regulation of MnSOD and GPx but not catalase increases oxidative stress and apoptosis. Cancer Res., 2004, 64(7), 2350-2356.
30. Yoon, K. A.; Nakamura, Y.; Arakawa, H. Identification of ALDH4 as a p53-inducible gene and its protective role in cellular stresses. J. Hum. Genet., 2004, 49(3), 134-140.
31. Stambolsky, P.; Weisz, L.; Shats, I.; Klein, Y.; Goldfinger, N.; Oren, M.; Rotter, V. Regulation of AIF expression by p53. Cell Death Differ., 2006, 13(12), 2140-2149.
32. Polyak, K.; Xia, Y.; Zweier, J. L.; Kinzler, K. W.; Vogelstein, B. A model for p53-induced apoptosis. Nature, 1997, 389(6648), 300-305.
33. Liu, Y.; Borchert, G. L.; Donald, S. P.; Diwan, B. A.; Anver, M.; Phang, J. M. Proline oxidase functions as a mitochondrial tumor suppressor in human cancers. Cancer Res., 2009, 69(16), 6414-6422.
34. Pandhare, J.; Donald, S. P.; Cooper, S. K.; Phang, J. M. Regulation and function of proline oxidase under nutrient stress. J. Cell Biochem., 2009, 107(4), 759-768.
35. Donald, S. P.; Sun, X. Y.; Hu, C. A.; Yu, J.; Mei, J. M.; Valle, D.; Phang, J. M. Proline oxidase, encoded by p53-induced gene-6, catalyzes the generation of proline-dependent reactive oxygen species. Cancer Res., 2001, 61(5), 1810-1815.
36. Liu, Y.; Borchert, G. L.; Donald, S. P.; Surazynski, A.; Hu, C. A.; Weydert, C. J.; Oberley, L. W.; Phang, J. M. MnSOD inhibits proline oxidase-induced apoptosis in colorectal cancer cells. Carcinogenesis, 2005, 26(8), 1335-1342.
37. Ide, T.; Brown-Endres, L.; Chu, K.; Ongusaha, P. P.; Ohtsuka, T.; El-Deiry, W. S.; Aaronson, S. A.; Lee, S. W. GAMT, a p53-inducible modulator of apoptosis, is critical for the adaptive response to nutrient stress. Mol. Cell, 2009, 36(3), 379-392.
38. Crighton, D.; Wilkinson, S.; O'Prey, J.; Syed, N.; Smith, P.; Harrison, P. R.; Gasco, M.; Garrone, O.; Crook, T.; Ryan, K. M. DRAM, a p53-induced modulator of autophagy, is critical for apoptosis. Cell, 2006, 126(1), 121-134.
39. Feng, Z.; Zhang, H.; Levine, A. J.; Jin, S. The coordinate regulation of the p53 and mTOR pathways in cells. Proc. Natl. Acad Sci. U S A., 2005, 102(23), 8204-8209.
40. Ravikumar, B.; Vacher, C.; Berger, Z.; Davies, J. E.; Luo, S.; Oroz, L. G.; Scaravilli, F.; Easton, D. F.; Duden, R.; O'Kane, C. J.; Rubinsztein, D. C. Inhibition of mTOR induces autophagy and reduces toxicity of polyglutamine expansions in fly and mouse models of Huntington disease. Nat Genet, 2004, 36(6), 585-595.
41. Amaravadi, R. K.; Yu, D.; Lum, J. J.; Bui, T.; Christophorou, M. A.; Evan, G. I.; Thomas-Tikhonenko, A.; Thompson, C. B. Autophagy inhibition enhances therapy-induced apoptosis in a Myc-induced model of lymphoma. J. Clin. Invest., 2007, 117(2), 326-336.
42. Zhang, H.; Bosch-Marce, M.; Shimoda, L. A.; Tan, Y. S.; Baek, J. H.; Wesley, J. B.; Gonzalez, F. J.; Semenza, G. L. Mitochondrial autophagy is an HIF-1-dependent adaptive metabolic response to hypoxia. J. Biol. Chem., 2008, 283(16), 10892-10903.
43. Tasdemir, E.; Chiara Maiuri, M.; Morselli, E.; Criollo, A.; D'Amelio, M.; Djavaheri-Mergny, M.; Cecconi, F.; Tavernarakis, N.; Kroemer, G. A dual role of p53 in the control of autophagy. Autophagy, 2008, 4(6), 810-814.
44. Tasdemir, E.; Maiuri, M. C.; Galluzzi, L.; Vitale, I.; Djavaheri-Mergny, M.; D'Amelio, M.; Criollo, A.; Morselli, E.; Zhu, C.; Harper, F.; Nannmark, U.; Samara, C.; Pinton, P.; Vicencio, J. M.; Carnuccio, R.; Moll, U. M.; Madeo, F.; Paterlini-Brechot, P.; Rizzuto, R.; Szabadkai, G.; Pierron, G.; Blomgren, K.; Tavernarakis, N.; Codogno, P.; Cecconi, F.; Kroemer, G. Regulation of autophagy by cytoplasmic p53. Nat. Cell Biol., 2008, 10(6), 676-687.
45. Bensaad, K.; Cheung, E. C.; Vousden, K. H. Modulation of intracellular ROS levels by TIGAR controls autophagy. EMBO J., 2009, 28(19), 3015-3026.
46. Budanov, A. V.; Karin, M. p53 target genes sestrin1 and sestrin2 connect genotoxic stress and mTOR signaling. Cell, 2008, 134(3), 451-460.
47. Feng, Z.; Hu, W.; de Stanchina, E.; Teresky, A. K.; Jin, S.; Lowe, S.; Levine, A. J. The regulation of AMPK beta1, TSC2, and PTEN expression by p53: stress, cell and tissue specificity, and the role of these gene products in modulating the IGF-1-AKT-mTOR pathways. Cancer Res., 2007, 67(7), 3043-3053.
48. Webster, N. J.; Resnik, J. L.; Reichart, D. B.; Strauss, B.; Haas, M.; Seely, B. L. Repression of the insulin receptor promoter by the tumor suppressor gene product p53: a possible mechanism for receptor overexpression in breast cancer. Cancer Res., 1996, 56(12), 2781-2788.
49. Werner, H.; Karnieli, E.; Rauscher, F. J.; LeRoith, D. Wild-type and mutant p53 differentially regulate transcription of the insulinlike growth factor I receptor gene. Proc. Natl. Acad Sci. U S A., 1996, 93(16), 8318-8323.
50. Kim, J. W.; Dang, C. V. Cancer's molecular sweet tooth and the Warburg effect. Cancer Res., 2006, 66(18), 8927-8930.
51. Papandreou, I.; Cairns, R. A.; Fontana, L.; Lim, A. L.; Denko, N. C. HIF-1 mediates adaptation to hypoxia by actively downregulating mitochondrial oxygen consumption. Cell Metab., 2006, 3(3), 187-197.
52. Zhang, H.; Gao, P.; Fukuda, R.; Kumar, G.; Krishnamachary, B.; Zeller, K. I.; Dang, C. V.; Semenza, G. L. HIF-1 inhibits mitochondrial biogenesis and cellular respiration in VHL-deficient renal cell carcinoma by repression of C-MYC activity. Cancer Cell, 2007, 11(5), 407-420.
53. Blagosklonny, M. V.; An, W. G.; Romanova, L. Y.; Trepel, J.; Fojo, T.; Neckers, L. p53 inhibits hypoxia-inducible factor-stimulated transcription. J. Biol. Chem., 1998, 273(20), 11995-11998.
54. Butow, R. A.; Avadhani, N. G. Mitochondrial signaling: the retrograde response. Mol. Cell, 2004, 14(1), 1-15.
55. Hardie, D. G.; Carling, D.; Carlson, M. The AMP-activated/SNF1 protein kinase subfamily: metabolic sensors of the eukaryotic cell? Annu. Rev. Biochem., 1998, 67, 821-855.
56. Jones, R. G.; Plas, D. R.; Kubek, S.; Buzzai, M.; Mu, J.; Xu, Y.; Birnbaum, M. J.; Thompson, C. B. AMP-activated protein kinase induces a p53-dependent metabolic checkpoint. Mol. Cell, 2005, 18(3), 283-93.
57. Mitra, K.; Wunder, C.; Roysam, B.; Lin, G.; Lippincott-Schwartz, J. A hyperfused mitochondrial state achieved at G1-S regulates cyclin E buildup and entry into S phase. Proc. Natl. Acad Sci. USA., 2009, 106(29), 11960-11965.
58. Okoshi, R.; Ozaki, T.; Yamamoto, H.; Ando, K.; Koida, N.; Ono, S.; Koda, T.; Kamijo, T.; Nakagawara, A.; Kizaki, H. Activation of AMPactivated protein kinase induces p53-dependent apoptotic cell death in response to energetic stress. J. Biol. Chem., 2008, 283(7), 3979-3987.
59. Muller, F. L.; Liu, Y.; Van Remmen, H. Complex III releases superoxide to both sides of the inner mitochondrial membrane. J. Biol. Chem., 2004, 279(47), 49064-49073.
60. Nohl, H.; Jordan, W. The metabolic fate of mitochondrial hydrogen peroxide. Eur. J. Biochem., 1980, 111(1), 203-210.
61. Brown, G. C.; Borutaite, V. Nitric oxide inhibition of mitochondrial respiration and its role in cell death. Free Radic. Biol. Med., 2002, 33(11), 1440-1450.
62. Han, D.; Williams, E.; Cadenas, E. Mitochondrial respiratory chain-dependent generation of superoxide anion and its release into the intermembrane space. Biochem. J., 2001, 353(Pt 2), 411-416.
63. Ballarin, C.; Sorgato, M. C. Anion channels of the inner membrane of mammalian and yeast mitochondria. J. Bioenerg. Biomembr., 1996, 28(2), 125-130.
64. Colombini, M.; Blachly-Dyson, E.; Forte, M. VDAC, a channel in the outer mitochondrial membrane. Ion. Channels., 1996, 4, 169-202.
65. Freeman, B. A.; Crapo, J. D. Biology of disease: free radicals and tissue injury. Lab. Invest., 1982, 47(5), 412-426.
66. Guidot, D. M.; Repine, J. E.; Kitlowski, A. D.; Flores, S. C.; Nelson, S. K.; Wright, R. M.; McCord, J. M. Mitochondrial respiration scavenges extramitochondrial superoxide anion via a nonenzymatic mechanism. J. Clin. Invest., 1995, 96(2), 1131-1136.
67. Hainaut, P.; Milner, J. Redox modulation of p53 conformation and sequence-specific DNA binding in vitro. Cancer Res., 1993, 53(19), 4469-4473.
68. Cobbs, C. S.; Whisenhunt, T. R.; Wesemann, D. R.; Harkins, L. E.; Van Meir, E. G.; Samanta, M. Inactivation of wild-type p53 protein function by reactive oxygen and nitrogen species in malignant glioma cells. Cancer Res., 2003, 63(24), 8670-8673.
69. Rainwater, R.; Parks, D.; Anderson, M. E.; Tegtmeyer, P.; Mann, K. Role of cysteine residues in regulation of p53 function. Mol. Cell Biol., 1995, 15(7), 3892-3903.
70. Holley, A. K.; St Clair, D. K. Watching the watcher: regulation of p53 by mitochondria. Future Oncol., 2009, 5(1), 117-130.
71. Nomura, T.; Kamada, R.; Ito, I.; Chuman, Y.; Shimohigashi, Y.; Sakaguchi, K. Oxidation of methionine residue at hydrophobic core destabilizes p53 tetrameric structure. Biopolymers, 2009, 91(1), 78-84.
72. Jayaraman, L.; Murthy, K. G.; Zhu, C.; Curran, T.; Xanthoudakis, S.; Prives, C. Identification of redox/repair protein Ref-1 as a potent activator of p53. Genes Dev., 1997, 11(5), 558-570.
73. Ueno, M.; Masutani, H.; Arai, R. J.; Yamauchi, A.; Hirota, K.; Sakai, T.; Inamoto, T.; Yamaoka, Y.; Yodoi, J.; Nikaido, T. Thioredoxin-dependent redox regulation of p53-mediated p21 activation. J. Biol. Chem., 1999, 274(50), 35809-35815.
74. Hu, J.; Ma, X.; Lindner, D. J.; Karra, S.; Hofmann, E. R.; Reddy, S. P.; Kalvakolanu, D. V., Modulation of p53 dependent gene expression and cell death through thioredoxin-thioredoxin reductase by the Interferon-Retinoid combination. Oncogene, 2001, 20(31), 4235-4248.
75. Karawajew, L.; Rhein, P.; Czerwony, G.; Ludwig, W. D. Stressinduced activation of the p53 tumor suppressor in leukemia cells and normal lymphocytes requires mitochondrial activity and reactive oxygen species. Blood, 2005, 105(12), 4767-4775.
76. Chandel, N. S.; Vander Heiden, M. G.; Thompson, C. B.; Schumacker, P. T. Redox regulation of p53 during hypoxia. Oncogene, 2000, 19(34), 3840-3848.
77. Renzing, J.; Hansen, S.; Lane, D. P. Oxidative stress is involved in the UV activation of p53. J. Cell Sci., 1996, 109 (Pt 5)(1105-1112.
78. Xu, D.; Finkel, T. A role for mitochondria as potential regulators of cellular life span. Biochem. Biophys. Res. Commun., 2002, 294(2), 245-248.
79. Harman, D. The biologic clock: the mitochondria? J. Am. Geriatr Soc., 1972, 20(4), 145-147.
80. Trinei, M.; Giorgio, M.; Cicalese, A.; Barozzi, S.; Ventura, A.; Migliaccio, E.; Milia, E.; Padura, I. M.; Raker, V. A.; Maccarana, M.; Petronilli, V.; Minucci, S.; Bernardi, P.; Lanfrancone, L.; Pelicci, P. G., A p53-p66Shc signalling pathway controls intracellular redox status, levels of oxidation-damaged DNA and oxidative stress-induced apoptosis. Oncogene, 2002, 21(24), 3872-3878.
81. Giorgio, M.; Migliaccio, E.; Orsini, F.; Paolucci, D.; Moroni, M.; Contursi, C.; Pelliccia, G.; Luzi, L.; Minucci, S.; Marcaccio, M.; Pinton, P.; Rizzuto, R.; Bernardi, P.; Paolucci, F.; Pelicci, P. G., Electron transfer between cytochrome c and p66Shc generates reactive oxygen species that trigger mitochondrial apoptosis. Cell, 2005, 122(2), 221-233.
82. Liu, Z.; Lu, H.; Shi, H.; Du, Y.; Yu, J.; Gu, S.; Chen, X.; Liu, K. J.; Hu, C. A. PUMA overexpression induces reactive oxygen species generation and proteasome-mediated stathmin degradation in colorectal cancer cells. Cancer Res, 2005, 65(5), 1647-1654.
83. Li, P. F.; Dietz, R.; von Harsdorf, R. p53 regulates mitochondrial membrane potential through reactive oxygen species and induces cytochrome c-independent apoptosis blocked by Bcl-2. EMBO J., 1999, 18(21), 6027-6036.
84. Hwang, P. M.; Bunz, F.; Yu, J.; Rago, C.; Chan, T. A.; Murphy, M. P.; Kelso, G. F.; Smith, R. A.; Kinzler, K. W.; Vogelstein, B. Ferredoxin reductase affects p53-dependent, 5-fluorouracil-induced apoptosis in colorectal cancer cells. Nat. Med., 2001, 7(10), 1111-1117.
85. Liu, G.; Chen, X. The ferredoxin reductase gene is regulated by the p53 family and sensitizes cells to oxidative stress-induced apoptosis. Oncogene, 2002, 21(47), 7195-7204.
86. Zhao, R.; Xiang, N.; Domann, F. E.; Zhong, W. Expression of p53 enhances selenite-induced superoxide production and apoptosis in human prostate cancer cells. Cancer Res., 2006, 66(4), 2296-2304.
87. Kulisz, A.; Chen, N.; Chandel, N. S.; Shao, Z.; Schumacker, P. T. Mitochondrial ROS initiate phosphorylation of p38 MAP kinase during hypoxia in cardiomyocytes. Am. J. Physiol. Lung Cell Mol. Physiol., 2002, 282(6), L1324-1329.
88. Bulavin, D. V.; Saito, S.; Hollander, M. C.; Sakaguchi, K.; Anderson, C. W.; Appella, E.; Fornace, A. J. Jr. Phosphorylation of human p53 by p38 kinase coordinates N-terminal phosphorylation and apoptosis in response to UV radiation. EMBO J., 1999, 18(23), 6845-6854.
89. Liu, J.; Mao, W.; Ding, B.; Liang, C. S. ERKs/p53 signal transduction pathway is involved in doxorubicin-induced apoptosis in H9c2 cells and cardiomyocytes. Am. J. Physiol. Heart Circ. Physiol., 2008, 295(5), H1956-1965.
90. Lou, H.; Danelisen, I.; Singal, P. K. Involvement of mitogenactivated protein kinases in adriamycin-induced cardiomyopathy. Am. J. Physiol. Heart Circ. Physiol., 2005, 288(4), H1925-930.
91. Chua, C. C.; Liu, X.; Gao, J.; Hamdy, R. C.; Chua, B. H. Multiple actions of pifithrin-alpha on doxorubicin-induced apoptosis in rat myoblastic H9c2 cells. Am. J. Physiol. Heart Circ. Physiol., 2006, 290(6), H2606-2613.
92. Chen, K.; Albano, A.; Ho, A.; Keaney, J. F. Jr. Activation of p53 by oxidative stress involves platelet-derived growth factor-beta receptor-mediated ataxia telangiectasia mutated (ATM) kinase activation. J. Biol. Chem., 2003, 278(41), 39527-39533.
93. Furukawa, A.; Tada-Oikawa, S.; Kawanishi, S.; Oikawa, S. H2O2 accelerates cellular senescence by accumulation of acetylated p53 via decrease in the function of SIRT1 by NAD+ depletion. Cell Physiol. Biochem., 2007, 20(1-4), 45-54.
94. Banin, S.; Moyal, L.; Shieh, S.; Taya, Y.; Anderson, C. W.; Chessa, L.; Smorodinsky, N. I.; Prives, C.; Reiss, Y.; Shiloh, Y.; Ziv, Y. Enhanced phosphorylation of p53 by ATM in response to DNA damage. Science, 1998, 281(5383), 1674-1677.
95. Nithipongvanitch, R.; Ittarat, W.; Cole, M. P.; Tangpong, J.; Clair, D. K.; Oberley, T. D. Mitochondrial and nuclear p53 localization in cardiomyocytes: redox modulation by doxorubicin (Adriamycin)? Antioxid Redox Signal, 2007, 9(7), 1001-1008.
96. Babcock, D. F.; Herrington, J.; Goodwin, P. C.; Park, Y. B.; Hille, B. Mitochondrial participation in the intracellular Ca2+ network. J. Cell Biol., 1997, 136(4), 833-844.
97. Amuthan, G.; Biswas, G.; Ananadatheerthavarada, H. K.; Vijayasarathy, C.; Shephard, H. M.; Avadhani, N. G. Mitochondrial stress-induced calcium signaling, phenotypic changes and invasive behavior in human lung carcinoma A549 cells. Oncogene, 2002, 21(51), 7839-7849.
98. Arnould, T.; Vankoningsloo, S.; Renard, P.; Houbion, A.; Ninane, N.; Demazy, C.; Remacle, J.; Raes, M. CREB activation induced by mitochondrial dysfunction is a new signaling pathway that impairs cell proliferation. EMBO J., 2002, 21(1-2), 53-63.
99. Marchenko, N. D.; Zaika, A.; Moll, U. M. Death signal-induced localization of p53 protein to mitochondria. A potential role in apoptotic signaling. J. Biol. Chem., 2000, 275(21), 16202-16212.
100. Speidel, D. Transcription-independent p53 apoptosis: an alternative route to death. Trends Cell Biol., 2009, 20(1), 14-24.
101. Ahn, B. Y.; Trinh, D. L.; Zajchowski, L. D.; Lee, B.; Elwi, A. N.; Kim, S. W. Tid1 is a new regulator of p53 mitochondrial translocation and apoptosis in cancer. Oncogene, 2010, 29(8), 1155-1166.
102. Marchenko, N. D.; Wolff, S.; Erster, S.; Becker, K.; Moll, U. M. Monoubiquitylation promotes mitochondrial p53 translocation. EMBO J., 2007, 26(4), 923-934.
103. Boopathi, E.; Srinivasan, S.; Fang, J. K.; Avadhani, N. G. Bimodal protein targeting through activation of cryptic mitochondrial targeting signals by an inducible cytosolic endoprotease. Mol. Cell, 2008, 32(1), 32-42.
104. Mancini, F.; Di Conza, G.; Pellegrino, M.; Rinaldo, C.; Prodosmo, A.; Giglio, S.; D'Agnano, I.; Florenzano, F.; Felicioni, L.; Buttitta, F.; Marchetti, A.; Sacchi, A.; Pontecorvi, A.; Soddu, S.; Moretti, F. MDM4 (MDMX) localizes at the mitochondria and facilitates the p53-mediated intrinsic-apoptotic pathway. EMBO J., 2009, 28(13), 1926-1939.
105. Liu, J.; St Clair, D. K.; Gu, X.; Zhao, Y. Blocking mitochondrial permeability transition prevents p53 mitochondrial translocation during skin tumor promotion. FEBS Lett., 2008, 582(9), 1319-1324.
106. Ventura, N.; Rea, S. L.; Schiavi, A.; Torgovnick, A.; Testi, R.; Johnson, T. E. p53/CEP-1 increases or decreases lifespan, depending on level of mitochondrial bioenergetic stress. Aging Cell, 2009, 8(4), 380-393.
107. Vousden, K. H.; Lu, X. Live or let die: the cell's response to p53. Nat. Rev. Cancer, 2002, 2(8), 594-604.
108. Buzek, J.; Latonen, L.; Kurki, S.; Peltonen, K.; Laiho, M. Redox state of tumor suppressor p53 regulates its sequence-specific DNA binding in DNA-damaged cells by cysteine 277. Nucleic Acids Res., 2002, 30(11), 2340-2348.
109. Macip, S.; Igarashi, M.; Berggren, P.; Yu, J.; Lee, S. W.; Aaronson, S. A. Influence of induced reactive oxygen species in p53-mediated cell fate decisions. Mol. Cell Biol., 2003, 23(23), 8576-8585.
110. Melov, S.; Schneider, J. A.; Day, B. J.; Hinerfeld, D.; Coskun, P.; Mirra, S. S.; Crapo, J. D.; Wallace, D. C. A novel neurological phenotype in mice lacking mitochondrial manganese superoxide dismutase. Nat. Genet., 1998, 18(2), 159-163.
111. Zhong, W.; Oberley, L. W.; Oberley, T. D.; Clair, St D. K. Suppression of the malignant phenotype of human glioma cells by overexpression of manganese superoxide dismutase. Oncogene, 1997, 14(4), 481-490.
112. Drane, P.; Bravard, A.; Bouvard, V.; May, E. Reciprocal downregulation of p53 and SOD2 gene expression-implication in p53 mediated apoptosis. Oncogene, 2001, 20(4), 430-439.
113. Dhar, S. K.; Xu, Y.; Chen, Y.; Clair, St D. K. Specificity protein 1-dependent p53-mediated suppression of human manganese superoxide dismutase gene expression. J. Biol. Chem., 2006, 281(31), 21698-21709.
114. Dhar, S. K.; Xu, Y.; Clair, St D. K. Nuclear factor kappa-B-and specificity protein 1-dependent p53-mediated bi-directional regulation of the human manganese superoxide dismutase gene. J. Biol. Chem., 2010, Jan 8, Epub.
115. Zhao, Y.; Chaiswing, L.; Velez, J. M.; Batinic-Haberle, I.; Colburn, N. H.; Oberley, T. D.; Clair, St D. K. p53 translocation to mitochondria precedes its nuclear translocation and targets mitochondrial oxidative defense protein-manganese superoxide dismutase. Cancer Res., 2005, 65(9), 3745-3750.
116. Mahyar-Roemer, M.; Fritzsche, C.; Wagner, S.; Laue, M.; Roemer, K. Mitochondrial p53 levels parallel total p53 levels independent of stress response in human colorectal carcinoma and glioblastoma cells. Oncogene, 2004, 23(37), 6226-6236.
117. Mummenbrauer, T.; Janus, F.; Muller, B.; Wiesmuller, L.; Deppert, W.; Grosse, F. p53 Protein exhibits 3'-to-5' exonuclease activity. Cell, 1996, 85(7), 1089-1099.
118. Lilling, G.; Elena, N.; Sidi, Y.; Bakhanashvili, M. p53-associated 3'-->5' exonuclease activity in nuclear and cytoplasmic compartments of cells. Oncogene, 2003, 22(2), 233-245.
119. Bakhanashvili, M.; Grinberg, S.; Bonda, E.; Simon, A. J.; Moshitch-Moshkovitz, S.; Rahav, G. p53 in mitochondria enhances the accuracy of DNA synthesis. Cell Death Differ., 2008, 15(12), 1865-1874.
120. de Souza-Pinto, N. C.; Harris, C. C.; Bohr, V. A. p53 functions in the incorporation step in DNA base excision repair in mouse liver mitochondria. Oncogene, 2004, 23(39), 6559-6568.
121. Yoshida, Y.; Izumi, H.; Torigoe, T.; Ishiguchi, H.; Itoh, H.; Kang, D.; Kohno, K. P53 physically interacts with mitochondrial transcription factor A and differentially regulates binding to damaged DNA. Cancer Res., 2003, 63(13), 3729-3734.
122. Wong, T. S.; Rajagopalan, S.; Townsley, F. M.; Freund, S. M.; Petrovich, M.; Loakes, D.; Fersht, A. R. Physical and functional interactions between human mitochondrial single-stranded DNAbinding protein and tumour suppressor p53. Nucleic Acids Res., 2009, 37(2), 568-581.
123. Nithipongvanitch, R.; Ittarat, W.; Velez, J. M.; Zhao, R.; Clair, St D. K.; Oberley, T. D. Evidence for p53 as guardian of the cardiomyocyte mitochondrial genome following acute adriamycin treatment. J. Histochem. Cytochem., 2007, 55(6), 629-639.
124. Kienhofer, J.; Haussler, D. J.; Ruckelshausen, F.; Muessig, E.; Weber, K.; Pimentel, D.; Ullrich, V.; Burkle, A.; Bachschmid, M. M. Association of mitochondrial antioxidant enzymes with mitochondrial DNA as integral nucleoid constituents. FASEB J., 2009, 23(7), 2034-2044.
125. Chen, Y.; Gibson, S. B. Is mitochondrial generation of reactive oxygen species a trigger for autophagy? Autophagy, 2008, 4(2), 246-248.
126. Scherz-Shouval, R.; Shvets, E.; Fass, E.; Shorer, H.; Gil, L.; Elazar, Z. Reactive oxygen species are essential for autophagy and specifically regulate the activity of Atg4. EMBO J., 2007, 26(7), 1749-1760.